Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spleen deficiency is a concept from Traditional Chinese Medicine (TCM) rather than a molecular or pharmacological target. In TCM, the "spleen" refers to an organ system responsible for digestion, energy production ("Qi"), nutrient transformation, blood containment, and fluid metabolism—not the anatomical spleen recognized in Western medicine[1][3][6]. Spleen Qi deficiency describes a pattern of symptoms such as fatigue, poor appetite, bloating after meals, loose stools or diarrhea, easy bruising, muscle weakness/heaviness, brain fog/difficulty concentrating—often attributed to factors like poor diet (especially cold/raw foods), overthinking/stress/mental strain, chronic illness or irregular eating habits[1][3][5][7]. Modern research has attempted to correlate this syndrome with measurable changes at the metabolic level—such as altered levels of certain metabolites and trace elements—and with changes in gut microbiota composition. However, there is no single molecule/receptor/protein that corresponds to "spleen deficiency"; it is not a receptor/enzyme/transporter/other canonical drug target but rather a holistic diagnostic category within TCM theory[2][4][6]. Some herbal formulas traditionally used to treat spleen deficiency have been studied for their effects on gut flora diversity and metabolic markers; these include Si Junzi Tang and others. Experimental biomarkers such as Shannon's index from ERIC-PCR analysis have been proposed for animal models but do not correspond to specific human molecular targets[8]. In summary: "Spleen deficiency" is not a therapeutic target molecule/receptor; it is an imprecise syndrome diagnosis unique to Traditional Chinese Medicine without direct correspondence to any known protein/gene/drug target.
Modulation of gut microbiota diversity and function[8] Regulation of digestive/metabolic pathways as interpreted in TCM (*Note*: Mechanisms are based on traditional concepts and some modern correlates but not molecular targets.)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen deficiency.